BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2021 9:33:19 AM | Browse: 496 | Download: 1185
 |
Received |
|
2021-02-24 09:34 |
 |
Peer-Review Started |
|
2021-02-24 09:39 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-06-04 05:04 |
 |
Revised |
|
2021-06-22 09:53 |
 |
Second Decision |
|
2021-07-29 02:54 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-07-29 06:01 |
 |
Articles in Press |
|
2021-07-29 06:01 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2021-08-18 08:18 |
 |
Publish the Manuscript Online |
|
2021-08-20 09:33 |
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Transplantation |
Manuscript Type |
Minireviews |
Article Title |
Kidney transplant from donors with hepatitis B: A challenging treatment option
|
Manuscript Source |
Invited Manuscript |
All Author List |
Praopilad Srisuwarn and Vasant Sumethkul |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Vasant Sumethkul, FACP, FRCP (Hon), MD, Full Professor, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama 6 Road, Ratchathewi, Bangkok 10400, Thailand. vasant.sum@mahidol.ac.th |
Key Words |
Hepatitis B virus; Organ donor; Recipient allocation; Kidney transplant; Transmission; Long term outcomes |
Core Tip |
Low-risk hepatitis B surface antigen (HBsAg) positive kidney donor, defined by a negative test of hepatitis B virus (HBV) DNA being allocated to immune-recipients with anti-HBs at least 10 mIU/mL is a key factor in overcoming the risk of HBV transmission. The risk may be further eliminated with optimal nucleos(t)ide analog prophylaxis. Blood tests for HBV DNA, HBs Ag, and liver function tests should be routinely monitored after transplantation and when there is a change of immunosuppression. The excellent long-term outcomes being reported suggested that the outcomes of this treatment option are promising. This will lead to broader use of organs with positive HBsAg. |
Publish Date |
2021-08-20 09:33 |
Citation |
Srisuwarn P, Sumethkul V. Kidney transplant from donors with hepatitis B: A challenging treatment option. World J Hepatol 2021; 13(8): 853-867 |
URL |
https://www.wjgnet.com/1948-5182/full/v13/i8/853.htm |
DOI |
https://dx.doi.org/10.4254/wjh.v13.i8.853 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345